Stay updated with breaking news from Consortium Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESULTS showed no signs of skin irritation or defects, no erythema, no edema was present at any time during the study. The primary irritation index of 0.0 out of a possible 8.0 on the pre-treated test
Megola Completes Successful Pilot Scale-Up Field Testing of its Patent-Pending ...
KINGSTON, Jamaica — Leslene Davis, a pioneer for women’s leadership in service to Jamaica in the areas of industrial development, contributions to national charitable causes and commercial and communi...
-Megola, Inc. (OTCMKTS:MGON)BONITA SPRINGS, FL / ACCESSWIRE / May 5, 2023 / (OTC-PINK:MGON) Megola, Inc. ("MGON", "Company") a Consortium Group of Health Technologies and Eco-Friendly Product Lines announced
The international BRACE trial, investigating the BCG vaccine's efficacy against COVID-19, has found it does not reduce healthcare workers' risk of contracting the disease. Future studies will explore the vaccine's influence on other infections and COVID-19 vaccine responses. A world-leading inter